NYSE

Hims & Hers Health, Inc.

HIMS

3 stories

$6.6B Market cap · 2026-10-14

Hims & Hers investor Paul Cerro is long again on lab and patient data driving retention and LTV, despite management concerns, GLP-1…

Yet Another Value Podcast Aug 7 9 clicks

Hims & Hers investor Paul Cerro is long again on labs and patient data raising retention and LTV, despite stagnant subscribers, GLP-1…

Yet Another Value Blog Aug 7 7 clicks

FDA’s crackdown on HIMS’s $49 compounded oral Wegovy copy reshapes GLP-1 competition after Novo Nordisk forecast 2026 sales and profit…

Modern Value Investing Feb 8

Investor Letters

Letters that discuss HIMS.

Companies the stories above are also about, besides HIMS.